MARCKSL1 and colorectal carcinoma: Furthermore, in EVs from metastatic CRC patients, myristoylated alanine-rich protein kinase C substrate-like protein 1 (MARCKSL1) has been identified as a potential biomarker, showing higher levels in patients with metastatic CRC compared to non-metastatic CRC and healthy individuals [82].